
Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia
Keywords: مهارکننده; Leukemia; Aurora B; FLT-3; Acyluriedoindolin-2-one; Inhibitors; Structure–activity relationshipAML, acute myeloid leukemia; FLT3, faline McDonough sarcoma like tyrosine kinase 3; RTK, receptor tyrosine kinase; ITD, internal tandem duplication; ATP, adenin